Clinical Trial: AD816 Crossover Study
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: OSA
Study Type: INTERVENTIONAL
Official Title: Phase 2 Randomized Double-Blind Placebo-Controlled Multiple-Dose 3-Period Crossover Study to Compare a Fixed Dose Combination of AD816 to Viloxazine Alone and to Placebo in Obstructive Sleep Apnea
Brief Summary:
The VicTor Study is a randomized, double blind, placebo-controlled, 3-period, multiple-dose crossover study in participants with OSA.
Read more